Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
about
CMV in Hematopoietic Stem Cell TransplantationCytomegalovirus infection in the bone marrow transplant patientCytomegalovirus antivirals and development of improved animal modelsHaploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectivesGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveCytomegalovirus: pathogen, paradigm, and puzzleSafety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationManipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection.Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.Organ-specific management and supportive care in chronic graft-versus-host disease.Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.Prevention and treatment of viral infections in stem cell transplant recipients.Beta-herpesvirus challenges in the transplant recipient.Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplantsHaematopoietic stem cell transplantation: indications, clinical developments and future directions.Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.Management of infectious complications in the hematopoietic stem cell transplant recipient.Pulmonary complications of solid organ and hematopoietic stem cell transplantation.Combating infections in hematopoietic stem cell transplant recipients.Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.Cytomegalovirus in hematopoietic stem cell transplant recipientsHost cell targets in HCV therapy: novel strategy or proven practice?Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.How we treat cytomegalovirus in hematopoietic cell transplant recipients.Diagnosis & management of cytomegalovirus infections in the GI tract.Comparison of two methods used for monitoring low-copy cytomegalovirus infection in a patient with chronic myeloid leukemia after unrelated umbilical cord blood transplantation.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Human cytomegalovirus infection and atherothrombosis.Management of multidrug-resistant viruses in the immunocompromised host.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.
P2860
Q26740385-749241FD-1836-45CA-900C-484D1C94C082Q26771385-DB68B069-F8AB-4E93-8E17-B20F805A00E4Q27000998-6CDC2710-180E-435A-8F28-87F1DC186398Q28080452-BCA37388-7EA2-4165-ADB1-268B28F7E82CQ28388806-8B7BBB4F-79D8-45D8-A0F8-03E78C0C6CA8Q33351523-0CF702AD-932A-4402-855D-334F913FA396Q33416429-CBBED314-4E3C-4ADE-BDAC-2231B450F762Q33427006-6C9A2BFD-FE26-4023-9D9A-1296CCABEC45Q33597783-4FE3366E-2414-49D5-9A4F-25ED4F0C5B8EQ33753996-0C6C1050-BCC4-41B8-8C14-861AF6493949Q33853830-BC9ABFE3-6F40-4148-B2D6-122FFE9F54A6Q34034462-866CDE24-E745-47D8-AF59-1F55FCCCFDBBQ34270868-EE49AB4D-D6DE-4617-80FD-3D930DA1E0DBQ34439235-1AB0DFFB-BC8D-46FD-918B-4D3A4B8B3173Q34722706-65BAEAAA-FC25-421C-8F34-1316540709B9Q34918418-9D9FA937-779D-483E-BCFB-325AA3B7B8CBQ35558815-A90BAF48-E18F-46F8-AD54-58CD83C16A86Q35609690-640ECBA4-297A-453D-8ECE-BFA4C308A662Q35668187-FAAB794A-278C-49C5-87A5-3351EA8D0FE4Q35675979-8A2F8D19-68EB-474C-A055-39926AAB627EQ35740698-51D10267-CE12-457A-9648-C0D821FDFA75Q35917135-78E1D40A-55BF-40B1-B96C-B053BB728D28Q35917480-85326B23-09FA-4623-AD3A-6B1733CF0528Q35922928-BA137394-11E6-4F48-AB03-CAF299CBD167Q36124729-586A53A2-45A2-4019-8F19-D05779B2E5D1Q36147994-F118C391-455D-412A-B4D4-899F2480F13AQ36367268-928C8449-CEEB-4B71-9648-E906032264C6Q36485256-D4CF3AB8-7162-4E51-9D02-93320EF3D46CQ37150434-65F8D328-D793-4F72-9E15-06185AEE1654Q37237427-265EDFE5-CFCC-4D53-9C96-6496415E9D2AQ37346001-004C4A37-97D2-44AE-B1DA-64845D5F73C0Q37395988-6D155702-9764-461B-9AC6-33868159CFDEQ37559627-86715430-3FCB-4005-83DC-2D6C6B631E2EQ37967568-CA47EB5E-5BBD-4FA5-868C-8532423D785BQ37970424-31E18785-F4DC-47E0-9CCE-15463C099E07Q38002109-6287E306-DC50-4794-9444-FC66985884B4Q38014916-783CF815-B65B-41F2-8035-DDB059ADBA5AQ38080794-CC04B764-A547-4A67-A11E-DBB8C1701E7EQ38541974-F22C81A8-91C6-479D-BFB8-F9BF18D16B0BQ38617612-32F93A11-BED0-4CF2-B53F-D248F840719A
P2860
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Randomized multicenter trial o ...... eic stem cell transplantation.
@ast
Randomized multicenter trial o ...... eic stem cell transplantation.
@en
type
label
Randomized multicenter trial o ...... eic stem cell transplantation.
@ast
Randomized multicenter trial o ...... eic stem cell transplantation.
@en
prefLabel
Randomized multicenter trial o ...... eic stem cell transplantation.
@ast
Randomized multicenter trial o ...... eic stem cell transplantation.
@en
P2093
P50
P356
P1433
P1476
Randomized multicenter trial o ...... eic stem cell transplantation.
@en
P2093
Catherine Cordonnier
Dan Engelhard
Hartmut Link
Infectious Diseases Working Pa ...... ood and Marrow Transplantation
Jürgen Finke
Montserrat Rovira
Pierre Reusser
P304
P356
10.1182/BLOOD.V99.4.1159
P407
P577
2002-02-01T00:00:00Z